These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 37958726)
1. A Serine Protease Inhibitor, Camostat Mesilate, Suppresses Urinary Plasmin Activity and Alleviates Hypertension and Podocyte Injury in Dahl Salt-Sensitive Rats. Iwata Y; Deng Q; Kakizoe Y; Nakagawa T; Miyasato Y; Nakagawa M; Nishiguchi K; Nagayoshi Y; Narita Y; Izumi Y; Kuwabara T; Adachi M; Mukoyama M Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958726 [TBL] [Abstract][Full Text] [Related]
2. The serine protease plasmin plays detrimental roles in epithelial sodium channel activation and podocyte injury in Dahl salt-sensitive rats. Deng Q; Kakizoe Y; Iwata Y; Nakagawa T; Miyasato Y; Nakagawa M; Nishiguchi K; Nagayoshi Y; Adachi M; Narita Y; Izumi Y; Kuwabara T; Tsuda Y; Mukoyama M Hypertens Res; 2023 Jan; 46(1):50-62. PubMed ID: 36241707 [TBL] [Abstract][Full Text] [Related]
3. Camostat mesilate inhibits prostasin activity and reduces blood pressure and renal injury in salt-sensitive hypertension. Maekawa A; Kakizoe Y; Miyoshi T; Wakida N; Ko T; Shiraishi N; Adachi M; Tomita K; Kitamura K J Hypertens; 2009 Jan; 27(1):181-9. PubMed ID: 19145783 [TBL] [Abstract][Full Text] [Related]
4. A serine protease inhibitor camostat mesilate prevents podocyte apoptosis and attenuates podocyte injury in metabolic syndrome model rats. Mizumoto T; Kakizoe Y; Nakagawa T; Iwata Y; Miyasato Y; Uchimura K; Adachi M; Deng Q; Hayata M; Morinaga J; Miyoshi T; Izumi Y; Kuwabara T; Sakai Y; Tomita K; Kitamura K; Mukoyama M J Pharmacol Sci; 2021 Aug; 146(4):192-199. PubMed ID: 34116732 [TBL] [Abstract][Full Text] [Related]
5. A serine protease inhibitor attenuates aldosterone-induced kidney injuries via the suppression of plasmin activity. Kakizoe Y; Miyasato Y; Onoue T; Nakagawa T; Hayata M; Uchimura K; Morinaga J; Mizumoto T; Adachi M; Miyoshi T; Sakai Y; Tomita K; Mukoyama M; Kitamura K J Pharmacol Sci; 2016 Oct; 132(2):145-153. PubMed ID: 27773435 [TBL] [Abstract][Full Text] [Related]
6. Proteolytic activation of the epithelial sodium channel and therapeutic application of a serine protease inhibitor for the treatment of salt-sensitive hypertension. Kitamura K; Tomita K Clin Exp Nephrol; 2012 Feb; 16(1):44-8. PubMed ID: 22038264 [TBL] [Abstract][Full Text] [Related]
7. High salt-induced weakness of anti-oxidative function of natriuretic peptide receptor-C and podocyte damage in the kidneys of Dahl rats. Zhu XL; Zhang T; Xu ZQ; Ma XC; Wang ZJ; Zou CW; Li JX; Jing HY Chin Med J (Engl); 2020 May; 133(10):1182-1191. PubMed ID: 32433050 [TBL] [Abstract][Full Text] [Related]
9. Podocyte injury underlies the glomerulopathy of Dahl salt-hypertensive rats and is reversed by aldosterone blocker. Nagase M; Shibata S; Yoshida S; Nagase T; Gotoda T; Fujita T Hypertension; 2006 Jun; 47(6):1084-93. PubMed ID: 16636193 [TBL] [Abstract][Full Text] [Related]
10. In vivo contribution of serine proteases to the proteolytic activation of γENaC in aldosterone-infused rats. Uchimura K; Kakizoe Y; Onoue T; Hayata M; Morinaga J; Yamazoe R; Ueda M; Mizumoto T; Adachi M; Miyoshi T; Shiraishi N; Sakai Y; Tomita K; Kitamura K Am J Physiol Renal Physiol; 2012 Oct; 303(7):F939-43. PubMed ID: 22832922 [TBL] [Abstract][Full Text] [Related]
11. Abnormal expression of ENaC and SGK1 mRNA induced by dietary sodium in Dahl salt-sensitively hypertensive rats. Aoi W; Niisato N; Sawabe Y; Miyazaki H; Tokuda S; Nishio K; Yoshikawa T; Marunaka Y Cell Biol Int; 2007 Oct; 31(10):1288-91. PubMed ID: 17485228 [TBL] [Abstract][Full Text] [Related]
12. Activation of G protein-coupled estrogen receptor 1 ameliorates proximal tubular injury and proteinuria in Dahl salt-sensitive female rats. Gohar EY; Almutlaq RN; Daugherty EM; Butt MK; Jin C; Pollock JS; Pollock DM; De Miguel C Am J Physiol Regul Integr Comp Physiol; 2021 Mar; 320(3):R297-R306. PubMed ID: 33407017 [TBL] [Abstract][Full Text] [Related]
13. Oxidative stress-induced glomerular mineralocorticoid receptor activation limits the benefit of salt reduction in Dahl salt-sensitive rats. Kitada K; Nakano D; Liu Y; Fujisawa Y; Hitomi H; Shibayama Y; Shibata H; Nagai Y; Mori H; Masaki T; Kobori H; Nishiyama A PLoS One; 2012; 7(7):e41896. PubMed ID: 22911865 [TBL] [Abstract][Full Text] [Related]
15. Enhancement of intrarenal angiotensinogen in Dahl salt-sensitive rats on high salt diet. Kobori H; Nishiyama A; Abe Y; Navar LG Hypertension; 2003 Mar; 41(3):592-7. PubMed ID: 12623964 [TBL] [Abstract][Full Text] [Related]
16. Regression of glomerular and tubulointerstitial injuries by dietary salt reduction with combination therapy of angiotensin II receptor blocker and calcium channel blocker in Dahl salt-sensitive rats. Rafiq K; Nishiyama A; Konishi Y; Morikawa T; Kitabayashi C; Kohno M; Masaki T; Mori H; Kobori H; Imanishi M PLoS One; 2014; 9(9):e107853. PubMed ID: 25233358 [TBL] [Abstract][Full Text] [Related]
17. Null mutation of the nicotinamide adenine dinucleotide phosphate-oxidase subunit p67phox protects the Dahl-S rat from salt-induced reductions in medullary blood flow and glomerular filtration rate. Evans LC; Ryan RP; Broadway E; Skelton MM; Kurth T; Cowley AW Hypertension; 2015 Mar; 65(3):561-8. PubMed ID: 25489057 [TBL] [Abstract][Full Text] [Related]
18. High salt loading induces urinary storage dysfunction via upregulation of epithelial sodium channel alpha in the bladder epithelium in Dahl salt-sensitive rats. Yamamoto S; Hotta Y; Maeda K; Kataoka T; Maeda Y; Hamakawa T; Shibata Y; Sasaki S; Ugawa S; Yasui T; Kimura K J Pharmacol Sci; 2017 Nov; 135(3):121-125. PubMed ID: 29129584 [TBL] [Abstract][Full Text] [Related]
19. Mineralocorticoid receptor blockade and calcium channel blockade have different renoprotective effects on glomerular and interstitial injury in rats. Du J; Fan YY; Hitomi H; Kiyomoto H; Kimura S; Kong CZ; Noma T; Kohno M; Nishiyama A; Nakano D Am J Physiol Renal Physiol; 2009 Sep; 297(3):F802-8. PubMed ID: 19535572 [TBL] [Abstract][Full Text] [Related]
20. Selective loss of podoplanin protein expression accompanies proteinuria and precedes alterations in podocyte morphology in a spontaneous proteinuric rat model. Koop K; Eikmans M; Wehland M; Baelde H; Ijpelaar D; Kreutz R; Kawachi H; Kerjaschki D; de Heer E; Bruijn JA Am J Pathol; 2008 Aug; 173(2):315-26. PubMed ID: 18599604 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]